Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro

Archives of Virology, Supplement

Volumn , Issue 16, 2001, Pages 265-273

  Post, K ^a   Brown, D R ^b   Groschup, M ^c   Kretzschmar, H A ^d   Riesner, D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28444477767     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Brown DR (2000) Neuronal release of vasoactive intestinal peptide is important to astrocytic protection of neurons from glutamate toxicity. Mol Cell Neurosci 15: 465-475
2. Brown DR, Pitschke M, Riesner D, Kretzschmar H (1998) Cellular effects of a neurotoxic prion protein peptide are related to its β-sheet content. Neurosci Res Commun 23: 119-128
3. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von-Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H (1997) The cellular prion protein binds copper in vivo. Nature 39: 684-687
4. Brown DR, Schmidt B, Kretzschmar HA (1996) A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia 18: 59-67
5. Brown DR, Schmidt B, Kretzschmar HA (1996) Role of microglia and host prion protein in neurotoxicity of prion protein fragment. Nature 380: 345-347
6. Forloni G, Angretti N, Chiesa R, Monzani E, Samona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment. Nature 362: 543-546
7. Forloni G, Tagliavini F, Bugiani O, Salmona M (1996) Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides. Progr Neurobiol 49: 287-315
8. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol 8: 449-457
9. Hill AF, Antoniou M, Collinge J (1999) Protease-resistant prion protein in vitro lacks detectable infectivity. J Gen Virol 80: 11-14
10. Kaneko K, Peretz D, Pan K-M, Blochberger TC, Wille H, Gabizon R, Griffith OH, Cohen F, Balwin MA, Prusiner SB (1995) Prion protein (PrP) synthetic peptide induce cellular PrP to acquire properties of the scrapie isoform. Proc Natl Acad Aci USA 92: 11160-11164
11. Kaneko K, Wille H, Mehlhorn I, Zhang H, Ball H, Cohen FE, Baldwin MA, Prusiner SB (1997a) Molecular properties of complexes formed between the prion protein and synthetic peptides. J Mol Biol 270: 547-586
12. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B (1994) Cell-free formation of protease-resistant prion protein. Nature 370: 471-474
13. Mehlhorn I, Groth D, Stöckel J, Moffat B, Reilly D, Yansuro D, Willet WS, Baldwin M, Fletterick R, Cohen FE, Vandlen R, Henner D, Prusiner SB (1996) High-level expression and characterisation of a purified 142-residue polypeptide of the prion protein. Biochemistry 35: 5528-5537
14. Post K, Pitschke M, Schäfer O, Wille H, Appel TR, Kirsch D, Mehlhorn I, Serban H, Prusiner SB, Riesner D (1998) Rapid acquisition of β-sheet structure in the prion protein prior to multimer formation. J Biol Chem 379: 1307-1317
15. Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515-1522
16. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM (1982) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11: 353-358
17. Prusiner SB, Me Kinley MP, Bowman KA, Bolton DC, Bendheim PE, Grothe DF, Glenner GG (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349-358
18. Riesner D, Kellings K, Post K, Wille H, Serban H, Groth D, Baldwin MB, Prusiner SB (1996) Disruption of prion rods generate 10-nm spherical particles having high α-helical content and lacking scrapie infectivity. J Virol 70: 1714-1722
19. Stege GJJ, Renkawek K, Overkamp PSG, Verschuure P, van Rijk AF, Reijnen-Aalbers A, Boelens WC, Bosman GJGM, DeJong WW (1999) The molecular chaperone αB-crystallin enhances amyloid β neurotoxicity. Biochem Biophys Res Commun 262: 152-156
20. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Bendek GB, Selkoe DJ, Teplow DB (1999) Amyloid β-protein fibrillogenesis. J Biol Chem 274: 25945-25952
21. Wille H, Zhang G-F, Baldwin MA, Cohen FE, Prusiner SB (1996) Separation of scrapie prion infectivity from PrP amyloid polymers. J Mol Biol 259: 608-621